BRIEF published on 03/31/2026 at 14:30, 6 months 22 days ago Le vaccin contre la maladie de Lyme de Valneva est prometteur malgré le non-respect du critère d'évaluation principal. Objectif De Cours Valneva SE Approbation De La FDA Essai De Phase 3 Vaccin Contre La Maladie De Lyme
BRIEF published on 03/31/2026 at 14:21, 6 months 22 days ago Worthington Steel's Successful Takeover of Klöckner & Co: Key Details Takeover Offer Mergers & Acquisitions Klöckner & Co Shareholder Acceptance Worthington Steel
BRIEF published on 03/31/2026 at 14:21, 6 months 22 days ago Rachat réussi de Klöckner & Co par Worthington Steel : points clés Offre Publique D'achat Klöckner & Co Fusions Et Acquisitions Acceptation Des Actionnaires Acier Worthington
BRIEF published on 03/31/2026 at 14:10, 6 months 22 days ago Whatfix Study: Enterprises Risk $10.9M Loss from Poor Digital Adoption AI Integration Governance Financial Loss Enterprise Technology Digital Adoption
BRIEF published on 03/31/2026 at 14:10, 6 months 22 days ago Étude Whatfix : Les entreprises risquent une perte de 10,9 millions de dollars en raison d’une faible adoption du numérique Gouvernance Intégration De L'IA Technologie D'entreprise Perte Financière Adoption Numérique
BRIEF published on 03/31/2026 at 14:10, 6 months 22 days ago Zvoove Group Bolsters Cleaning Industry Solutions with KleanApp Acquisition Digital Operations Cleaning Industry Europe Expansion Zvoove Group KleanApp Acquisition
BRIEF published on 03/31/2026 at 14:10, 6 months 22 days ago Le groupe Zvoove renforce ses solutions pour l'industrie du nettoyage avec l'acquisition de KleanApp. Expansion Européenne Industrie Du Nettoyage Opérations Numériques Groupe Zvoove Acquisition De KleanApp
BRIEF published on 03/31/2026 at 14:05, 6 months 22 days ago Proxygen Names Chiara Conti as Chief Scientific Officer Biotechnology Clinical Development Molecular Glue Degraders Proxygen GmbH Chiara Conti
BRIEF published on 03/31/2026 at 14:05, 6 months 22 days ago Proxygen nomme Chiara Conti au poste de directrice scientifique Biotechnologie Développement Clinique Dégradeurs De Colle Moléculaire Proxygen GmbH Chiara Conti
BRIEF published on 03/31/2026 at 14:05, 6 months 22 days ago Lonza Nominates Stephen Fry as Independent Board Member Pharmaceutical Industry Governance Organizational Transformation Lonza Board Stephen Fry
Published on 10/23/2026 at 02:20, 3 hours 53 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 6 hours 43 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 7 hours 43 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 14 hours 13 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 15 hours 43 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 06:05, 7 minutes ago Baccarat Hotel & Residences Maldives Unveils New Campaign featuring Adriana Lima
Published on 10/23/2026 at 01:55, 4 hours 17 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 8 hours 2 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 10 hours 13 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 10 hours 28 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:00, 12 hours 13 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 12 hours 13 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 12 hours 13 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 12 hours 13 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 12 hours 13 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
